Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider APBI in a primary breast adenoid cystic carcinoma?
Assuming the patient is otherwise a candidate for APBI.
Answer from: Radiation Oncologist at Community Practice
I would be reluctant based on local spread pattern.
Comments
Radiation Oncologist at Henry Ford Health System
Given this tumor type's high degree of local sprea...
3084
Sign in or Register to read more
7769
Related Questions
Would you offer APBI to a patient with very large breast anatomy and a small lumpectomy cavity after an oncoplastic closure?
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Would you consider omitting PMRT in cT3N0 triple negative breast cancer with a pCR?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?
What evidence supports the use of high tangents for pN1mic breast cancer?
How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?
How would you approach an isolated supraclavicular nodal recurrence involving the skin in a patient who has received standard chest wall and nodal radiation therapy?
In a clinically node negative early stage breast cancer patient who underwent neoadjuvant systemic therapy, would surgical finding of fibrosis suspicious for treatment effect in sentinel nodes impact your RT decision?
Are you comfortable combining palliative radiotherapy with capivasertib/fulvestrant?
Given this tumor type's high degree of local sprea...